Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma
, , , , , , , oraz
03 gru 2020
O artykule
Kategoria artykułu: Research Article
Data publikacji: 03 gru 2020
Zakres stron: 66 - 76
Otrzymano: 21 lip 2020
Przyjęty: 06 paź 2020
DOI: https://doi.org/10.2478/raon-2020-0070
Słowa kluczowe
© 2021 Cuimeng Tian, Guimei Liu, Yongxiang Xu, Guangrong Xia, Tongmei Zhang, Jiaqiang Huang, Hui Jiang, Ji Ming Wang, Baolan Li, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Figure 1

Figure 2

Univariate analyses of the factors affecting overall survival (OS), loco-regional recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) of lung squamous cell carcinoma (LADC) patients (N = 194)
Characteristics | No. | OS | LRFS | DMFS | |||
---|---|---|---|---|---|---|---|
5-year OS, % | P | 5-year LRFS, % | P | 5-year DMFS, % | P | ||
0.071 | 0.085 | 0.139 | |||||
| 96 | 48.2 | 46.9 | 44.1 | |||
| 98 | 39.6 | 37.1 | 30.6 | |||
0.751 | 0.811 | 0.494 | |||||
| 139 | 43.6 | 41.6 | 34.5 | |||
| 55 | 45.0 | 42.8 | 41.3 | |||
0.001* | 0.001* | 0.006* | |||||
| 127 | 50.4 | 49.4 | 44.5 | |||
| 67 | 31.0 | 27.4 | 22.7 | |||
0.468 | 0.158 | 0.319 | |||||
| 178 | 44.1 | 42.3 | 36.5 | |||
| 16 | 41.7 | 38.5 | 37.5 | |||
0.032* | 0.020* | 0.001* | |||||
| 166 | 46.3 | 44.0 | 40.4 | |||
| 28 | 29.5 | 28.0 | 15.5 | |||
0.001* | 0.002* | 0.000* | |||||
| 46 | 60.9 | 58.3 | 58.8 | |||
| 62 | 37.9 | 38.8 | 37.8 | |||
| 86 | 38.7 | 35.4 | 22.5 | |||
0.000* | 0.000* | 0.000* | |||||
| 87 | 56.6 | 54.7 | 53.4 | |||
| 107 | 33.3 | 31.4 | 20.4 | |||
0.000* | 0.001* | 0.000* | |||||
| 80 | 54.8 | 52.7 | 51.8 | |||
| 114 | 35.7 | 34.0 | 26.9 | |||
0.001* | 0.002* | 0.001* | |||||
| 46 | 60.9 | 58.3 | 58.8 | |||
| 148 | 38.3 | 36.9 | 29.0 | |||
0.169 | 0.280 | 0.541 | |||||
| 24 | 34.4 | 36.5 | 37.5 | |||
| 170 | 44.9 | 43.0 | 36.6 | |||
0.948 | 0.723 | 0.440 | |||||
| 152 | 45.0 | 43.0 | 38.8 | |||
| 42 | 40.0 | 40.0 | 28.7 |
Multivariate analyses of the factors affecting overall survival (OS), loco-regional recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) of lung adenocarcinoma (LSCC) patients (N = 85)
Characteristics | OS | LRFS | DMFS | |||
---|---|---|---|---|---|---|
HR (95% CI) | P | HR(95% CI) | P | HR (95% CI) | P | |
0.789 | 0.823 | 0.563 | ||||
| 1 | 1 | 1 | |||
| 0.905(0.436–1.880) | 0.922(0.454–1.874) | 0.806(0.389–1.672) | |||
0.208 | 0.149 | 0.151 | ||||
| 1 | 1 | 1 | |||
| 1.436(0.817–2.522) | 1.524(0.860–2.701) | 1.522(0.858–2.699) | |||
0.257 | 0.296 | 0.664 | ||||
| 1 | 1 | 1 | |||
| 1.618(0.704–3.715) | 1.556(0.679–3.563) | 1.194(0.537–2.657) | |||
0.440 | 0.454 | 0.330 | ||||
| 1 | 1 | 1 | |||
| 1.322(0.650–2.689) | 1.308(0.648–2.643) | 1.428(0.697–2.925) | |||
0.922 | 0.963 | 0.813 | ||||
| 1 | 1 | 1 | |||
| 1.043(0.447–2.436) | 0.979(0.409–2.343) | 0.903(0.385–2.114) | |||
0.127 | 0.224 | 0.496 | ||||
| 1 | 1 | 1 | |||
| 0.523(0.227–1.202) | 0.595(0.258–1.374) | 0.751(0.328–1.715) | |||
0.017* | 0.006* | 0.013* | ||||
| 1 | 1 | 1 | |||
| 0.364(0.159–1.832) | 0.308(0.133–0.712) | 0.349(0.152–0.802) |
Univariate analyses of the factors affecting overall survival (OS), loco-regional recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) of lung adenocarcinoma (LSCC) patients (N = 85)
Characteristics | No | OS | LRFS | DMFS | |||
---|---|---|---|---|---|---|---|
5-year OS, % | P | 5-year LRFS, % | P | 5-year DMFS, % | P | ||
0.670 | 0.784 | 0.762 | |||||
| 7 | 42.9 | 42.9 | 42.9 | |||
| 78 | 43.2 | 39.1 | 41.3 | |||
0.362 | 0.617 | 0.447 | |||||
| 60 | 46.4 | 40.8 | 43.9 | |||
| 25 | 36.0 | 36.0 | 36.0 | |||
0.713 | 0.659 | 0.767 | |||||
| 18 | 55.6 | 44.4 | 50.0 | |||
| 67 | 39.6 | 37.8 | 39.0 | |||
0.283 | 0.375 | 0.498 | |||||
| 57 | 47.6 | 42.4 | 45.5 | |||
| 28 | 34.1 | 33.2 | 33.9 | |||
0.341 | 0.289 | 0.237 | |||||
| 56 | 46.4 | 44.1 | 47.1 | |||
| 29 | 37.0 | 30.3 | 31.8 | |||
0.625 | 0.596 | 0.882 | |||||
| 31 | 50.6 | 44.4 | 44.8 | |||
| 26 | 41.3 | 37.8 | 41.2 | |||
| 28 | 35.2 | 34.3 | 38.1 | |||
0.115 | 0.161 | 0.431 | |||||
| 45 | 49.2 | 45.2 | 46.1 | |||
| 40 | 36.7 | 34.1 | 36.1 | |||
0.152 | 0.154 | 0.265 | |||||
| 51 | 48.7 | 43.8 | 46.9 | |||
| 34 | 34.4 | 33.0 | 33.1 | |||
0.367 | 0.363 | 0.654 | |||||
| 31 | 50.6 | 44.4 | 44.8 | |||
| 54 | 38.9 | 36.9 | 39.7 | |||
0.316 | 0.371 | 0.525 | |||||
| 13 | 30.8 | 30.8 | 30.8 | |||
| 72 | 45.3 | 40.9 | 43.5 | |||
0.026* | 0.008** | 0.018* | |||||
| 66 | 37.7 | 32.5 | 35.3 | |||
| 19 | 63.2 | 63.2 | 63.2 |
Multivariate analyses of the factors affecting overall survival (OS), loco-regional recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) of lung squamous cell carcinoma (LADC) patients (N = 194)
Characteristics | OS | LRFS | DMFS | |||
---|---|---|---|---|---|---|
HR (95% CI) | P | HR(95% CI) | P | HR (95% CI) | P | |
0.000* | 0.000* | 0.005* | ||||
| 1 | 1 | 1 | |||
| 2.172(1.471–3.207) | 2.098(1.421–3.099) | 1.739(1.181–2.560) | |||
0.074 | 0.156 | 0.002* | ||||
| 1 | 1 | 1 | |||
| 1.560(0.958–2.542) | 1.428(0.873–2.337) | 2.120(1.308–3.435) | |||
0.255 | 0.234 | 0.134 | ||||
| 1 | 1 | 1 | |||
| 1.403(0.783–2.512) | 1.441(0.789–2.632) | 1.624(0.861–3.062) | |||
0.392 | 0.435 | 0.471 | ||||
| 1 | 1 | 1 | |||
| 1.313(0.704–2.447) | 1.291(0.680–2.452) | 1.283(0.651–2.528) | |||
0.015* | 0.046* | 0.141 | ||||
| 1 | 1 | 1 | |||
| 2.065(1.148–3.714) | 1.818(1.010–3.272) | 1.565(0.863–2.839) | |||
0.004* | 0.031* | 0.047* | ||||
| 1 | 1 | 1 | |||
| 0.417(0.230–0.757) | 0.524(0.291–0.942) | 0.554(0.310–0.992) | |||
0.759 | 0.737 | 0.444 | ||||
| 1 | 1 | 1 | |||
| 1.074(0.680–1.697) | 0.924(0.584–1.463) | 1.196(0.756–1.891) |
Patient characteristics
Characteristic | LADC ( N = 194 ) | LSCC ( N = 85 ) | ||||||
---|---|---|---|---|---|---|---|---|
Total, n (%) | Non-PORT, n (%) | PORT, n (%) | P | Total, n (%) | Non-PORT, n (%) | PORT, n (%) | P | |
0.262 | 0.593 | |||||||
| 96(49.5) | 72(47.4) | 24(57.1) | 7(8.2) | 6(9.1) | 1(5.3) | ||
| 98(50.5) | 80(52.6) | 18(42.9) | 78(91.8) | 60(90.9) | 18(94.7) | ||
0.058 | 0.814 | |||||||
| 139(71.6) | 104(68.4) | 35(83.3) | 60(70.6) | 47(71.2) | 13(68.4) | ||
| 55(28.4) | 48(31.6) | 7(16.7) | 25(29.4) | 19(28.8) | 6(31.6) | ||
0.199 | 0.058 | |||||||
| 127(65.5) | 96(63.2) | 31(73.8) | 18(21.2) | 11(16.7) | 7(36.8) | ||
| 67(34.5) | 56(36.8) | 11(26.2) | 67(78.8) | 55(83.3) | 12(63.2) | ||
0.028 | 0.211 | |||||||
| 178(91.8) | 136(89.5) | 42(100) | 57(84.0) | 42(63.6) | 15(78.9) | ||
| 16(8.2) | 16(10.5) | 0(0.0) | 28(16.0) | 24(36.4) | 4(21.1) | ||
0.044 | 0.167 | |||||||
| 166(85.6) | 126(82.9) | 40(95.2) | 56(65.9) | 46(69.7) | 10(52.6) | ||
| 28(14.4) | 26(17.1) | 2(4.8) | 29(34.1) | 20(30.3) | 9(47.4) | ||
0.228 | 0.989 | |||||||
| 46(23.7) | 38(25.0) | 8(19.0) | 31(36.5) | 24(36.4) | 7(36.8) | ||
| 62(32.0) | 44(28.9) | 18(42.9) | 26(30.6) | 20(30.3) | 64(31.6) | ||
| 86(44.3) | 70(46.1) | 16(38.1) | 28(32.9) | 22(33.3) | 6(31.6) | ||
0.090 | 0.581 | |||||||
| 87(44.8) | 73(48.0) | 14(33.3) | 45(52.9) | 36 (54.5) | 9(47.4) | ||
| 107(55.2) | 79(52.0) | 28(66.7) | 40(47.1) | 30(45.5) | 10(52.6) | ||
0.060 | 0.832 | |||||||
| 80(41.2) | 68(44.7) | 12(28.6) | 51(60.0) | 40(60.6) | 11(57.9) | ||
| 114(58.8) | 84(55.3) | 30(71.4) | 34(40.0) | 26(39.4) | 8(42.1) | ||
0.422 | 0.970 | |||||||
| 46(23.7) | 38(25.0) | 8(19.0) | 31(36.5) | 24(36.4) | 7(36.8) | ||
| 148(76.3) | 114(75.0) | 34(81.0) | 54(63.5) | 42(63.6) | 12(63.2) | ||
0.026 | 0.512 | |||||||
| 24(12.4) | 23(15.1) | 1(2.4) | 13(15.3) | 11(16.7) | 2(10.5) | ||
| 170(87.6) | 129(84.9) | 41(97.6) | 72(84.7) | 55(83.3) | 17(89.5) |